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Abstract
The gut-derived hormone ghrelin exerts its effect on the brain by regulating neuronal activity.
Ghrelin-induced feeding behaviour is controlled by arcuate nucleus neurons that co-express
neuropeptide Y and agouti-related protein (NPY/AgRP neurons). However, the intracellular
mechanisms triggered by ghrelin to alter NPY/AgRP neuronal activity are poorly understood.
Here we show that ghrelin initiates robust changes in hypothalamic mitochondrial respiration in
mice that are dependent on uncoupling protein 2 (UCP2). Activation of this mitochondrial
mechanism is critical for ghrelin-induced mitochondrial proliferation and electric activation of
NPY/AgRP neurons, for ghrelin-triggered synaptic plasticity of pro-opiomelanocortin-expressing
neurons, and for ghrelin-induced food intake. The UCP2-dependent action of ghrelin on NPY/
AgRP neurons is driven by a hypothalamic fatty acid oxidation pathway involving AMPK, CPT1
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and free radicals that are scavenged by UCP2. These results reveal a signalling modality
connecting mitochondria-mediated effects of G-protein-coupled receptors on neuronal function
and associated behaviour.
Ghrelin alters neuronal activity in various brain regions including the hypothalamus1,
hippocampus2 and midbrain3. Ghrelin activates NPY/AgRP neurons of the arcuate
nucleus1,4 to suppress proopiomelanocortin (POMC) neuronal activity while promoting food
intake. However, the intracellular mechanisms that mediate NPY/AgRP neuronal activation
in response to ghrelin remain unknown.
Uncoupling proteins are inner-membrane mitochondrial proteins that are important for
bioenergetics of diverse tissues5–8. UCP2 is strongly expressed in the hypothalamus
including NPY/AgRP neurons of the arcuate nucleus9,10 where ghrelin receptors (growth
hormone secretagogue receptor 1; GHSR) are also expressed11. Ghrelin enhances Ucp2
mRNA [Author: Note that we italicise at the gene and mRNA level (the gene symbol here
follows that for mouse). Please check that this is consistent throughout the paper.]
expression in the pancreas12, liver13 and white adipose tissue14, and hypothalamic Ucp2
mRNA levels and protein activity [Author: ‘Ucp2 mRNA levels and protein activity’
correct?Yes!] are elevated during fasting9, when circulating ghrelin is increased15. Thus, we
analysed whether UCP2 is involved in hypothalamic neuronal responses to ghrelin and
associated food intake.
Ghrelin induces mitochondrial respiration via UCP2
Immunohistochemistry revealed the presence of GHSR [Author: GHSR (singular) correct
yes, Ucp2–/– mice correct?] in greater than 90% of UCP2-expressing, β-galactosidase-
positive arcuate nucleus neurons in Ucp2–/– (ref. 16) mice (Supplementary Fig. 1a–c).
To analyse whether ghrelin affects mitochondrial respiration, we studied isolated
hypothalamic synaptosomes17 in ghrelin- and saline-treated animals. Mitochondrial
respiration (given as nmol of oxygen consumed per minute per mg protein) was significantly
increased after adding pyruvate and malate (state 2; saline 32.07 ± 1.38 and ghrelin 44.83 ±
3.15, P < 0.05, wild-type mice). [Author: Revised sentence ok?Yes.] The subsequent
addition of ADP (state 3) increased respiration in the ghrelin-treated mice relative to saline
controls (saline 99.39 ± 3.51 and ghrelin 155.98±5.36, [Author: 155.98±] P < 0.05, wild-
type mice). Ghrelin increased basal uncoupling status after ATP synthase inhibition with
oligomycin (saline 27.2 ± 2.2 and ghrelin 37.3 ± 1.6, P < 0.05, wild-type mice; Fig. 1a) and
free-fatty-acid (palmitate)-induced respiration (saline 150.0 ± 5.7 and ghrelin 170.1 ± 4.7, P
< 0.05, wild-type mice; Fig. 1b). Finally, total respiratory capacity induced by
carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone (FCCP) was also increased by
ghrelin (saline 297.0 ± 7.7 and ghrelin 427.9 ± 19.2, P < 0.05, wild-type mice; Fig. 1c).
These increases were dependent on UCP2, as no significant elevation was seen for the above
respiration parameters in Ucp2–/– mice compared to their saline controls (Fig. 1a–c).
Genipin, a compound reported to be a specific UCP2 inhibitor18, inhibited oxygen
consumption in all states of mitochondrial respiration in all tissues studied from both wild-
type and Ucp2–/– mice (Supplementary Table 1).
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In assessing whether ghrelin’s effect on UCP2 activation involves Ucp2 gene expression, we
found that ghrelin produced a robust increase in hypothalamic Ucp2 mRNA in wild-type
mice, but not in Gshr–/– mice (Supplementary Fig. 1d). Ghrelin also stimulated Npy gene
expression in the arcuate nucleus in a UCP2- (Fig. 1e) and GHSR-dependent
(Supplementary Fig. 1e) manner. Finally, ghrelin-induced AgRP expression also depended
on UCP2 (Supplementary Fig. 1f). Ghrelin had no effect on POMC (Supplementary Fig.
1g).
Ghrelin induces UCP2-mediated mitochondrial proliferation
During fasting the number of mitochondria in NPY/AgRP perikarya increases in a UCP2-
dependent manner9. Ghrelin, which is elevated during fasting, also increased mitochondrial
number in NPY neuronal perikarya in wild-type but not Ucp2–/– mice (Fig. 1f and
Supplementary Fig. 1h, i). The number of mitochondria in POMC–GFP perikarya was
unaffected (Supplementary Fig. 1j). Because we observed a ghrelin-induced, UCP2- and
GSHR-dependent increase in nuclear respiratory factor 1 (Nrf1; Fig. 1g) expression,
[Author: Nrf1 correct, as this panel shows Nrf1 mRNA?Yes.] a transcription factor that
stimulates mitochondrial biogenesis, we propose that the change in mitochondrial number in
NPY/AgRP neurons may also involve de novo mitochondrial biogenesis. This is supported
by the observation that peroxisome proliferator-activated receptor-γ coactivator 1α
(PGC1A) enhances mitochondrial biogenesis and respiration in association with robust
induction of UCP2 and NRF1 (ref. 8).
The above results on perikaryal mitochondria number and from counts of synaptosomal
mitochondria from hypothalamic tissue of wild-type or Ucp2–/– mice treated with ghrelin or
saline (see Supplementary Fig. 2a–g), together with ghrelin’s effect on state 3 respiration
and total respiration capacity of synaptosomal mitochondria, suggest that elevated oxygen
consumption by mitochondria in response to ghrelin arises in part from increased
mitochondrial number. [Author: Revised sentence ok?Yes.]
Ghrelin alters mitochondrial membrane potential via UCP2
In peripheral tissues19,20 UCP2 alters mitochondrial membrane potential. Thus, we analysed
the mitochondrial membrane potential in synaptosomes of ghrelin- or saline-treated wild-
type and Ucp2–/– mice. Ghrelin-treated wild-type synaptosomes exhibited lower
mitochondrial membrane potential after addition of pyruvate and malate (state 2: 78.43 ±
8.61% of saline values; P < 0.05) and oligomycin (state 4: 75.13 ± 4.87% of saline values; P
< 0.05) compared to saline-treated wild-type synaptosomes (Fig. 1h). [Author: Revised
sentence ok?Yes.] These differences were absent in Ucp2–/– mice (Supplementary Fig. 3a).
These observations suggest that a component of the altered oxygen consumption induced by
ghrelin may also arise from increased uncoupled respiration; however, further studies are
needed to strengthen these findings and study the basal differences in mitochondrial
membrane potential kinetics in wild-type and Ucp2–/– mice.
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Ghrelin-induced NPY/AgRP activation is dependent on UCP2
As a surrogate of neuronal activation, c-fos expression was examined in response to ghrelin
in NPY neurons using mice expressing NPY–GFP on the Ucp2–/– background (NPY–GFP/
Ucp2–/– mice). [Author: Revised sentence ok?Yes.] After ghrelin injection, total NPY/c-
fos dual labelling was significantly attenuated in NPY–GFP/Ucp2–/– mice compared to
NPY–GFP/wild-type mice (wild type 602.33 ± 98.50, Ucp2–/– 298.40 ± 64.59, P < 0.05;
Fig. 2a and Supplementary Fig. 3b–d). Neither total NPY cell number nor arcuate nucleus
volume was affected by genotype or ghrelin treatment (Supplementary Fig. 3e, f). No
difference was observed in POMC–GFP/Ucp2–/– mice (Supplementary Fig. 3g–i).
Next, patch-clamp whole-cell electrophysiological recordings in slice preparations from
NPY–GFP/wild type and NPY–GFP/Ucp2–/– mice showed that ghrelin increased action
potential firing in all NPY neurons; however, it was severely attenuated in Ucp2–/– mice
compared to wild-type animals (Fig. 2b and Supplementary Fig. 4a). This defect was
specific to the action of ghrelin on NPY neurons, as glutamate produced normal responses in
wild-type and Ucp2–/– mice (Supplementary Fig. 4b). Ghrelin had no effect on POMC–GFP
neuronal action potential frequency. These results are concordant with anatomical
observations showing that 94% of NPY and just 8% of POMC neurons express GHSRs11.
Ghrelin-induced synaptic plasticity is mediated by UCP2
Ghrelin indirectly hyperpolarizes POMC neurons by activating inhibitory NPY/AgRP
inputs1, and, consistent with this, ghrelin-induced recruitment of miniature inhibitory
postsynaptic currents (mIPSCs) on POMC cells was significantly elevated in wild-type
animals (153.8 ± 22.4%, n = 5), but not in Ucp2–/– mice (100.5 ± 2.5%, n = 5; Fig. 2c and
Supplementary Fig. 4c).
Changes in mIPSCs are associated with synaptic plasticity21–23. Corresponding to the
mIPSC measurements, ghrelin treatment increased symmetric, putatively inhibitory
synapses on POMC neurons in wild-type (saline 8.33 ± 0.97 and ghrelin 16.55 ± 1.68) but
not in Ucp2–/– mice (saline 7.23 ± 1.63 and ghrelin 9.12 ± 1.63; Fig. 2d). Conversely,
ghrelin significantly reduced the number of asymmetric, putatively excitatory synapses on
POMC neurons in wild-type mice (saline 15.75 ± 1.89 and ghrelin 8.66 ± 1.05) but not in
Ucp2–/– mice (Supplementary Fig. 4d). Although the inhibitory input of POMC neurons
arises partially from arcuate nucleus NPY/AgRP neurons, the origin of the stimulatory
synapses needs further exploration.
UCP2 mediates ghrelin-induced food intake
To determine whether the UCP2-dependent cellular responses described above are relevant
for behaviour, we analysed the feeding behaviour of wild-type and Ucp2–/– mice in response
to ghrelin administration (intraperitoneal, 10 nmol) at the beginning of the dark phase (Fig.
2e). At 1, 2 and 3 h after injection, ghrelin-induced hyperphagia was severely attenuated in
Ucp2–/– mice compared to wild-type mice (1 h: wild type 4.45 ± 0.24, Ucp2–/– 2.23 ± 0.19,
P < 0.01; 2 h: wild type 4.41 ± 0.36, Ucp2–/– 1.72 ± 0.03, P < 0.001; Fig. 2e, units are fold
intake relative to saline controls). [Author: Revised sentence ok?Yes.] We and others
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recently demonstrated that ghrelin can act at multiple sites in the brain to induce food
intake3,21. Thus, we injected ghrelin (500 pmol μl−1) locally into the mediobasal
hypothalamus or ventral tegmental area (VTA) (Supplementary Fig. 4e, f) [Author: Please
define VTA. Done.] immediately before the dark phase. At all time points, intra-mediobasal
hypothalamus ghrelin-induced food intake was significantly lower in Ucp2–/– mice
compared to wild type (Fig. 2f). Intra-VTA, ghrelin-induced food intake was also attenuated
in Ucp2–/– mice compared to wild type at 1 h but not at 2 or 3 h after ghrelin injection
(Supplementary Fig. 4g). These data suggest that UCP2 regulates ghrelin-induced feeding
behaviour in both the mediobasal hypothalamus and VTA. The longer lasting effect of
ghrelin in the mediobasal hypothalamus suggests that mediobasal hypothalamus control
dominates ghrelin-induced feeding behaviour and is consistent with the finding that mice
with conditional knockout of arcuate nucleus NPY/AgRP neurons in adulthood do not
respond to ghrelin24.
We also tested the effect of leptin-reduced food intake in Ucp2–/– mice compared to wild-
type controls. No significant effects were observed between the two groups (Supplementary
Fig. 5a, b).
Ghrelin induces AMPK and ACC phosphorylation
Ghrelin increases AMPK activity within the hypothalamus25, including NPY/AgRP
neurons26, which promotes feeding25,27 and enhances mitochondrial biogenesis and function
in the periphery28,29. We found that ghrelin promotes AMPK phosphorylation (pAMPK/
AMPK ratio) in a GHSR-dependent manner (Fig. 3a) in both wild-type and Ucp2–/– mice
(Fig. 3b), indicating that ghrelin's action on AMPK is downstream of GHSR but upstream of
UCP2. We also observed that ghrelin elevates phosphorylated acetyl-CoA carboxylase
(ACC), consistent with increased AMPK activity (Fig. 3b). [Author: Please define ACC.
Done. Correct definition of i.c.v.?] Intracerebroventricular (i.c.v.) injection of a stimulator of
AMPK activity, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR), like
ghrelin, increased both mitochondrial coupled and uncoupled respiration in the
hypothalamus of wild-type but not Ucp2–/– mice (Supplementary Fig. 6a). In addition,
AICAR promoted food intake in both wild-type and Ghsr–/– mice in a similar manner (Fig.
3c), whereas AICAR-induced food intake was significantly diminished in Ucp2–/– mice
compared to wild type (Fig. 3d). Intracerebroventricular injection [Author: Please clarify
term ‘central injection’] of compound C, an inhibitor of AMPK, inhibited food intake
induced after peripheral ghrelin injections in wild-type mice, but did not further decrease
food intake in Ucp2–/– animals (Fig. 3e), and, it also prevented ghrelin-induced elevations in
Ucp2 mRNA levels in wild-type mice (Fig. 3f). [Author: Revised sentence ok?Yes.] These
results confirm that ghrelin activates AMPK signalling through the GHSR, and reveal that
AMPK requires UCP2 to exert an effect on feeding.
Ghrelin-induced food intake is mediated by CPT1
AMPK activation and ACC inhibition lead to a reduction in malonyl-CoA and release of
carnitine palmitoyltransferase 1 (CPT1) from allosteric inhibition. Increased CPT1 activity
enhances oxidation of long chain fatty acids (LCFA) and increases food intake30. Ghrelin
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increased the expression of hypothalamic Cpt1 mRNA (Fig. 3g) and this was dependent on
AMPK activity, as intracerebroventricularly administered compound C blocked this effect
(Fig. 3g). The induction of Cpt1 mRNA by ghrelin occurred rapidly, after just 1 h
(Supplementary Fig. 6b). Ghrelin-triggered elevation in Ucp2, Npy and Nrf1 mRNA levels
also occurred after 1 h (Supplementary Fig. 6c). The ghrelin-induced increase in Ucp2
mRNA levels was diminished by concomitant intracerebroventricular administration of
either compound C or etomoxir (CPT1 inhibitor) (Fig. 3f), confirming that ghrelin-induced
Ucp2 mRNA expression is mediated by the AMPK–CPT1 pathway. Furthermore, etomoxir
and compound C prevented the ghrelin-induced increase in both Npy and Agrp gene
expression (Fig. 3h and Supplementary Fig. 6d), mimicking the impairments found in
Ucp2–/– mice (see Fig. 1e and Supplementary Fig. 1f). No difference in Pomc mRNA was
observed in any group (data not shown). In line with the mRNA expression data, etomoxir
also suppressed ghrelin-induced food intake (Fig. 3i).
The aforementioned data indicate that CPT1 activation, similar to AMPK activation, is
upstream of UCP2. However, we found that ghrelin-induced elevation of hypothalamic Cpt1
mRNA levels is not observable in Ucp2–/– animals (Fig. 3j). This apparent paradox is
resolved in studies described below regarding hypothalamic free radicals.
Ghrelin raises hypothalamic LCFA CoAs and blood NEFAs
To assess whether ghrelin increases the availability of substrates for mitochondrial beta
oxidation coinciding with AMPK and CPT1 activation, we analysed hypothalamic levels of
LCFA CoAs 3 h after ghrelin administration. Total LCFA CoAs (comprising both 16- and
18-carbon LCFA CoAs) were significantly higher in the hypothalamus of ghrelin- versus
saline-treated controls (saline 29.15 ± 1.17, ghrelin 33.72 ± 1.15 nmol metabolite per g
tissue; P < 0.05; n = 4 and 6 respectively; Supplementary Fig. 6e). Next, we analysed LCFA
CoAs in the hypothalamus at 0, 30, 60, 120 and 180 min after ghrelin administration.
Compared to time 0 (36.18 ± 2.25 nmol metabolite per g tissue), by 30 min (in the absence
of food) hypothalamic LCFA CoA levels were significantly elevated (40.75 ± 1.55 nmol
metabolite per g tissue, P < 0.05) and remained high through 60 (43.08 ± 0.95 nmol
metabolite per g tissue), 120 (42.24 ± 0.62 nmol metabolite per g tissue) and 180 min (40.9
± 0.42 nmol metabolite per g tissue; Supplementary Fig. 6f). Although no statistical
differences were detected between these values, the trend suggests that from 60 min
onwards, hypothalamic levels of LCFA CoAs may start to descend (Supplementary Fig. 6f),
perhaps due to increased use and oxidation of LCFA CoAs. Supporting this idea is the
paradigm in which chronically elevated ghrelin (20 h of fasting) resulted in depletion of
hypothalamic levels of LCFA CoAs31. We also found that non-esterified fatty acid (NEFA)
levels in the circulation (0.23 ± 0.3 mequiv. l−1 at time 0) start to rise 30 min after ghrelin
injection (0.30 ± 0.3 mequiv. l−1, P > 0.05), and become significantly higher at 60 (0.42 ±
0.3 mequiv. l−1, P < 0.01), 120 (0.51 ± 0.07 mequiv. l−1) and 1,080 min [Author: Do you
mean 180 min? No, it is 1,080 min as 18 hours. mequiv. for milliequivalent ok? Yes.] (1.09
± 0.11 mequiv. l−1, P < 0.00001) (Supplementary Fig. 6g). The elevated NEFA levels during
negative energy balance accompanied by an initial rise but subsequent decline in
hypothalamic LCFA CoA levels is consistent with the conclusions of ref. 31 suggesting that
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the source of hypothalamic LCFA CoAs is the periphery, and also with our observations that
hypothalamic LCFA CoAs may undergo beta oxidation.
Ghrelin reduces ROS in NPY/AgRP neurons via UCP2
A by-product of increased mitochondrial fatty acid beta oxidation is increased ROS
production32,33. Ghrelin significantly increased synaptosomal ROS in Ucp2–/– but not in
wild-type hypothalami compared to saline controls (Fig. 4a). Next, we injected ghrelin or
saline together with dihydroethidium bromide (DHE), a compound that fluoresces as it is
oxidized, to analyse in situ ROS levels in NPY–GFP and POMC–GFP mice on wild-type
and Ucp2–/– backgrounds. There was no difference in DHE levels [Author: Do you mean
there was no difference in the amount of fluorescent DHE?Yes.] in NPY neurons of wild-
type animals treated with either ghrelin or saline (Fig. 4b and Supplementary Fig. 7).
However, ghrelin treatment of Ucp2–/– animals resulted in increased levels of DHE in NPY
neurons compared to saline controls (Fig. 4b and Supplementary Fig. 7). The analysis of
randomly selected, non-GFP-positive cells showed a shift in DHE levels similar to that seen
in NPY neurons (quantified data not shown). In contrast, however, DHE levels in POMC–
GFP neurons were significantly higher in wild-type mice treated with saline compared to
those given ghrelin (Fig. 4b and Supplementary Fig. 7). In Ucp2–/– mice, lower levels of
DHE were observed in POMC neurons in both the saline- and ghrelin-treated mice (Fig. 4b
and Supplementary Fig. 7). Overall these data are consistent with UCP2's putative ability to
buffer ROS levels.
ROS scavenging reverses responses of Ucp2 –/– mice
In light of the data on ROS, we hypothesized that the paradoxical lack of Cpt1 mRNA
induction by ghrelin in Ucp2–/– animals (Fig. 3j) may be due to an effect of ROS on CPT1.
Thus, we injected a ROS scavenging cocktail containing ascorbic acid (10 μM), N-acetyl-L-
cysteine (10 μM) and TEMPO (1 μM) intracerebroventricularly into wild-type or Ucp2–/–
mice with a concurrent intraperitoneal injection of ghrelin (10 nmol). Scavenging of ROS
enabled ghrelin to induce elevated Cpt1 mRNA levels in Ucp2–/– mice (Fig. 4c).
Our results support the hypothesis that ghrelin-triggered ROS production promotes UCP2
activity and mRNA expression and that the main action of UCP2 in these circuits is to
promote ROS scavenging. In line with this, we found that after intracerebroventricular
injection of ROS scavenging cocktail, ghrelin-induced elevations in hypothalamic Ucp2
mRNA levels in wild-type mice were diminished (Supplementary Fig. 8a), which was
paralleled by rescue of induction of Npy and Agrp mRNA levels by ghrelin in Ucp2−/− mice
(Fig. 4d and Supplementary Fig. 8b). In addition, incubating isolated hypothalamic
synaptosomes from ghrelin-treated wild-type mice with the ROS scavenging cocktail
suppressed ghrelin-induced increases in mitochondrial uncoupled respiration after
oligomycin treatment but not in state 3 or FCCP-driven respiration (Supplementary Fig. 8c).
When hypothalamic slices from Ucp2−/− mice were incubated (for 20 min) with the ROS
scavenging cocktail, ghrelin-evoked NPY neuronal firing was also restored to wild-type
values (Figs 2b and 4e). Moreover, in the presence of the ROS scavenger, washout of
ghrelin did not silence NPY neurons (Fig. 4e), indicating that the intracellular events
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triggered by ghrelin not only potentiated but also maintained neuronal firing subsequent to
the initial ghrelin signalling. In association with the effect of ROS scavenger on cellular
events in the hypothalamus of Ucp2–/– mice, ghrelin’s ability to promote feeding was
restored as well in Ucp2–/– mice pre-treated with the ROS scavenger (Fig. 4f).
Discussion
We have identified intracellular events that contribute to appropriate activation of NPY/
AgRP neurons in response to ghrelin (Supplementary Fig. 9). Ghrelin induces a rapid
increase of NPY/AgRP neuronal firing by activation of GHSR. Ghrelin, via GHSR, also
results in AMPK activation that suppresses ACC activity, eliminating the inhibition of
CPT1. CPT1 activation can enhance LCFA entry into mitochondria and increase beta
oxidation. Fatty acid beta oxidation promotes generation of ROS32,33, which together with
fatty acids promote UCP2 transcription and activity34. UCP2 activity neutralizes ROS35,
thereby allowing continuous CPT1-promoted fatty acid beta oxidation that enables
continuous support of the bioenergetic needs to maintain firing of NPY/AgRP cells.
Sustained firing of NPY/AgRP neurons, the efferents of which are GABAergic36,37 onto
POMC neurons, results in activity-dependent synaptic plasticity promoting an organization
of increased inhibitory input onto POMC neurons leading to increased feeding. Our results
also indicate that fatty acids, which are elevated in the circulation concurrently with ghrelin
during fasting15, are acutely increased in the hypothalamus in response to ghrelin
administration so that they can serve as a continuous fuel supply for NPY/AgRP neurons
during negative energy balance. In light of previous work34, we predict that the absence of
fatty acid beta oxidation such as during increased carbohydrate load or positive energy
balance may affect UCP2 activation and lead to a different cellular outcome. In support of
this, it was recently reported that elevated glucose levels in animals on a high fat diet
promote UCP2 induction, which was paralleled with impaired ability of POMC neurons to
sense glucose38. The apparent elevated baseline ROS levels in POMC neurons are consistent
with the possibility of increased carbohydrate fuel-based activity in these cells at the time of
relative satiety (when UCP2 would not be activated), because carbohydrates, and glucose in
particular, are major generators of ROS through increasing electron transport at complex 1.
Because NPY neurons show lower ROS production than POMC neurons, it is tempting to
speculate that the NPY/AgRP neurons are less susceptible to free-radical-induced damage,
leading to resistance of orexigenic hypothalamic mechanisms to cellular stress. Conversely,
POMC cells may be more vulnerable to free-radical-induced damage and progressive
degeneration, which may have relevance to age-related onset of obesity. Because GHSR and
UCP2 expression overlaps in other brain sites, including the midbrain, we predict that
ghrelin modulation of other brain functions will also be regulated by UCP2-modulated fatty
acid metabolism.
METHODS SUMMARY
Detailed methodology can be found in the Supplementary Information. In short, tissue
preparation, immunocytochemistry, synaptosomal respiration, Real-time PCR, quantitative
and qualitative electron microscopic analyses of mitochondria and synapse number,
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electrophysiology and feeding behaviour analyses were performed as previously
described1–3,9,23,36,39.
The mitochondrial membrane potential was measured in isolated synaptosomal
mitochondrial fractions from the hypothalamus using ΔΨm-sensitive TMRE and fluorescent
spectrofluorophotometry. Non-esterified fatty acids were measured in plasma using a
colorimetric non-esterified fatty acid (NEFA) kit (Wako) following the manufacturer’s
instructions. LCFA CoAs were measured by mass spectroscopy.
ROS production was quantified using dichlorodihydrofluorescein diacetate (DCF) in
mitochondrial fractions and using DHE in fixed tissue.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Mitochondrial and transcriptional effects of ghrelin are UCP2-mediated
a–c, Ghrelin alters hypothalamic mitochondrial respiration. a, Oligomycin inhibits ATP
synthase and uncouples substrate oxidation from ATP phosphorylation. The resulting
increase in uncoupled oxygen consumption in ghrelin-treated mice is due to UCP2, as
Ucp2–/– mice exhibit no response to ghrelin. b, Ghrelin enhances respiration after palmitate
addition in wild-type but not Ucp2–/– mice. [Author: Revised sentence ok?Yes.] c, An
increase in respiration after FCCP shows that ghrelin enhances the maximal respiratory
capacity in wild-type but not in Ucp2–/– mice. d, Ghrelin increases (10 nmol) hypothalamic
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Ucp2 mRNA expression as measured by real-time PCR (n = 6). The data are expressed as a
fold increase relative to saline levels. e, Arcuate Npy gene expression is increased in
response to ghrelin in wild-type but not Ucp2–/– mice (n = 6). f, Ghrelin promotes
mitochondrial proliferation in a UCP2-dependent manner in arcuate NPY/AgRP cells.
[Author: Should this be NPY/AgRP cells, as per panel label?Yes.] g, Ghrelin increases Nrf1
mRNA expression in the hypothalamus of wild-type but not Ucp2–/– mice. h, Representative
traces showing that ghrelin decreases the mitochondrial membrane potential after addition of
energy substrates (state 2) and after addition of oligomycin (state 4). Asterisk indicates
statistically significant differences (P < 0.05) with respect to saline controls. All error bars
indicate s.e.m. [Author: Correct definition of error bars?Yes.] Olig, oligomycin; Palm,
palmitate; Pyr/Mal, pyruvate and malate. [Author: Correct definitions? ΔΨm correct for y
axis label?Yes.]
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Figure 2. Effects of ghrelin on neuronal firing, synaptic plasticity and feeding are UCP2-
mediated
a, UCP2 potentiates NPY c-fos activation in the arcuate nucleus in response to ghrelin (10
nmol). Stereological analysis of total NPY–GFP/c-fos cells in the arcuate nucleus of wild-
type (n = 6) and Ucp2–/– mice (n = 6) is shown. b, Ghrelin increases mean action potential
frequency of NPY–GFP neuronal perikarya in whole-cell recordings from wild-type mice (n
= 7); this effect is diminished in Ucp2–/– mice (n = 7). [Author: Revised sentence ok?] c,
Ghrelin increases the frequency of mIPSCs on POMC–GFP perikarya in wild type but not in
Andrews et al. Page 14
Nature. Author manuscript; available in PMC 2014 July 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Ucp2–/– mice (n = 5 for both groups). d, Ghrelin increases the number of symmetric,
putatively inhibitory perikaryal synapses on POMC neurons in wild-type mice but not in
Ucp2–/– mice. [Author: ‘Number per 100 μm [micrometres] perikarya’ correct for y axis of
d?Yes.] e, Peripheral ghrelin administration (intraperitoneal) significantly (P < 0.05)
enhances food intake relative to saline controls in both wild-type (n = 6) and Ucp2–/– (n = 6)
mice at 1, 2 and 3 h after injection. However, food intake in Ucp2–/– mice is significantly
attenuated compared to wild-type mice 1, 2 and 3 h after injection. f, Mediobasal
hypothalamus ghrelin injection (500 pmol μl−1) significantly increases food intake of both
genotypes at 1, 2 and 3 h after injection. However, Ucp2–/– mice display severely attenuated
food intake at all time points compared to wild-type controls. Asterisk indicates statistically
significant differences (P < 0.05) with respect to saline controls; dagger indicates
statistically significant (P < 0.05) reduction with respect to ghrelin-treated wild-type mice.
All error bars indicate s.e.m. [Author: Correct definition of error bars?Yes.]
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Figure 3. Ghrelin activates an intracellular pathway of fatty acid metabolsim
a, Ghrelin increases the pAMPK/AMPK ratio in wild-type but not Ghsr–/– mice (n = 5).
Ghr, ghrelin; Sal, saline. b, Ghrelin increases the pAMKP/AMPK ratio and phosphorylates
downstream ACC in both wild-type and Ucp2–/– mice, indicating that activation of AMPK
is upstream to increased UCP2 activity (n = 6). c–e, AMPK regulation affects food intake. c,
AICAR significantly increases food intake relative to saline controls in wild-type and
Ghsr–/– mice. d, AICAR-induced food intake is significantly suppressed in Ucp2–/– mice
compared to controls, indicating that UCP2 is required to translate AMPK activity into a
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complete food intake response (n = 5). e, AICAR significantly increases cumulative 3-h
food intake relative to saline controls; however, this effect is completely blocked with a
concurrent intracerebroventricular injection of compound C (CC, 6 μg μl−1), an inhibitor of
AMPK activity. AICAR did not affect the cumulative 3-h food intake in Ucp2–/– mice and
this was not affected by concurrent intracerebroventricular injection of compound C. f,
Intraperitoneal ghrelin administration increases hypothalamic Ucp2 mRNA; however, this
increase is blocked by concurrent injection of etomoxir or CC, indicating that activation of
the AMPK–CPT1 pathway is important in the regulation of Ucp2 mRNA expression. g,
Intraperitoneal ghrelin administration increases hypothalamic Cpt1 mRNA expression;
[Author: On the figure, f is labelled Ucp3 mRNA and g is labelled Cpt1 mRNA. Please
correct as necessary.] however, the induction of Cpt1 mRNA with ghrelin (Ghr) is blocked
when the CPT1 inhibitor etomoxir (Eto), or compound C (CC), is injected
intracerebroventricularly. h, Peripheral ghrelin injection increases hypothalamic expression
of Npy mRNA, which is completely suppressed by intracerebroventricular injection of
etomoxir and CC. Note that in f–h mRNA expression was not affected by
intracerebroventricular injection of etomoxir or compound C with saline injected
intraperitoneally. [Author: Revised sentence ok?Yes.] i, Inhibition of CPT1 activity with
an intracerebroventricular injection of etomoxir suppresses ghrelin-induced (IP 10 nmol)
food intake compared to mice receiving intraperitoneal ghrelin and intracerebroventricular
saline (Ghr/Sal). Neither intracerebroventricular etomoxir nor compound C affected food
intake in mice treated intraperitoneally with saline (n = 5–7). j, Ghrelin increased Cpt1
mRNA expression in wild-type but not in Ucp2–/– mice (n = 6, P < 0.05). Asterisk,
statistically significant (P < 0.05) with respect to saline controls; dagger, statistically
significant (P < 0.05) with respect to Ghr/Sal. [Author: Please clarify ‘c’ label in panel g;
statistically significant (P<0.05) with respect to Ghr/Eto.] All error bars indicate s.e.m.
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Figure 4. ROS is a critical regulator of cellular and behavioural responses to ghrelina
Ghrelin increases hypothalamic synaptosomal ROS production in Ucp2–/– mice but not
wild-type mice (n = 4–5). b, Quantification of ROS production shows that ghrelin markedly
increases in situ ROS in NPY neurons in Ucp2–/– but not wild-type mice. c, Suppressed
Cpt1 mRNA expression in ghrelin-treated Ucp2–/– mice after 3 h is completely reversed and
elevated above wild-type levels by concurrent intracerebroventricular injection of free
radical scavenging (FRS) cocktail (n = 5, P < 0.05). i.c.v., intracerebroventricular; i.p.,
intraperitoneal. d, FRS cocktail reverses suppressed Npy mRNA in ghrelin-treated Ucp2–/–
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mice. e, Incubating arcuate slices with FRS restores suppressed NPY neuronal action
potential firing in Ucp2–/– mice. Neurons were from NPY–GFP/Ucp2–/– mice. Asterisk,
significant to 100% saline controls. f, The FRS cocktail reverses the suppressed ghrelin-
induced food intake after 1 h in Ucp2–/– mice (n = 9, P < 0.05). Except for e: asterisk,
significant to saline controls; dagger, significant decrease compared to wild-type mice
administered ghrelin intraperitoneally and saline intracerebroventricularly; double dagger,
significant with respect to Ucp2–/– mice administered ghrelin intraperitoneally and saline
intracerebroventricularly.
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